Author: [AUTHOR] Published on 12/1/2018 12:00:00 AM

Satyawan B. Jadhav, PhD, Post‐Doctoral Associate Research, University of Florida College of Pharmacy, Gainesville, Florida

Dr. Jadhav decided to join ASCPT to network with professionals and become familiar with the latest trends in the field of clinical pharmacology and pharmacometrics. His current mentor at the University of Florida, Dr. Hartmut Derendorf, introduced him to ASCPT. He was also referred to the Society by his friend and colleague, Dr. Hardik Chandasana, who is also at the University of Florida.

ASCPT membership provides Dr. Jadhav with a great opportunity to interact with other professionals. He believes that his membership will allow him to keep abreast with current developments in the field. He also feels that it provides him with a large platform with which to share his work and obtain expert input on that work. He views ASCPT journal access and member‐exclusive webinars as “icing on the cake.” He also hopes to learn more about various career opportunities through the ASCPT Career Center.

Currently, Dr. Jadhav is evaluating pharmacokinetics and tissue distribution of an anticancer mAb in tumor xenografts using large pore microdialysis. He is developing a translational pharmacokinetic/pharmacodynamic (PK/PD) model incorporating relevant target site (tumor ISF) concentrations of biotherapeutics describing experimental data, which he believes would provide meaningful insight to aid dose selection to further its preclinical and clinical development. Additionally, he is working on PBPK models for evaluation of drug‐drug interaction potential between statins and anti‐infective agents.

Dr. Jadhav is a scientist with 10 years of broad range experience from small molecule preclinical discovery to phase I clinical development stage. He has served as a reviewer for Clinical Pharmacology & Therapeutics (CPT) as well as Clinical and Translational Science (CTS).